Potassium Chloride
NDC Package 81033-412-32
Package Information
Potassium Chloride is a medication a mineral supplement used to treat or prevent low amounts of potassium in the blood. Marketed by Kesin Pharma, this product is identified by NDC 81033-412 and is authorized under FDA application ANDA216156.
Identification & Billing
- RxCUI: 312515 - potassium chloride 20 MEQ in 15 mL Oral Solution
- RxCUI: 312515 - potassium chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - K+ Chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - Pot Chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - potassium chloride 1.5 GM per 15 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81033 - Kesin Pharma
- 81033-412 - Potassium Chloride
- 81033-412-32 - 100 CUP, UNIT-DOSE in 1 CASE / 30 mL in 1 CUP, UNIT-DOSE (81033-412-30)
- 81033-412 - Potassium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (81033-412). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81033-412-32 identifies a specific commercial package of 100 cup, unit-dose in 1 case / 30 ml in 1 cup, unit-dose (81033-412-30) of Potassium Chloride, labeled by Kesin Pharma. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kesin Pharma on June 10, 2024. The current certification is valid through December 31, 2025.
What are the primary indications for this medication?
This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.
How is this Kesin Pharma product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033041232. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
